Skip to main content

Advertisement

Log in

Epidemiology, Clinical Features, and Management of Texas Coral Snake (Micrurus tener) Envenomations Reported to the North American Snakebite Registry

  • Original Article
  • Published:
Journal of Medical Toxicology Aims and scope Submit manuscript

Abstract

Introduction

Few of the 5000–8000 snakebites reported to poison control centers annually in the USA are attributed to coral snakes. This study describes Texas coral snake envenomations reported to the North American Snakebite Registry.

Methods

All Texas coral snake envenomation cases reported to the registry were identified for the period from January 1, 2015, through December 31, 2019. Data reviewed for this study included details regarding the snake encounter, patient demographics, signs and symptoms, treatment, and outcomes. Descriptive statistics were used to report results.

Results

Ten men and four nonpregnant women reported coral snake bites. The median patient age was 15.5 (range 5–72 years). There were 12 upper extremity bites and two bites to the lower extremity. The most common symptoms reported were paresthesias and pain. All subjects had paresthesias, often described as an “electric” sensation. Seven patients described them as painful. The most common clinical findings were erythema and swelling. No patient developed tissue damage, hematotoxicity, rhabdomyolysis, hypotension, weakness, or respiratory symptoms. Thirteen subjects were treated with opioids. Six patients were treated with antiemetics: three prophylactically and two for opioid-induced nausea. One patient developed nausea and non-bloody, nonbilious emesis within 1 hour of the bite, prior to receiving opioids. No patients were treated with antivenom. Antibiotics were not administered to any patient, and no infections were reported.

Conclusions

Envenomations from M. tener in Southeast Texas are characterized by painful paresthesias. Mild swelling and erythema are common. Neurotoxicity necessitating antivenom or mechanical ventilation did not occur.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
€32.70 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (Finland)

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Mowry JB, Spyker DA, Cantilena LR Jr, Bailey JE, Ford M. 2012 annual report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 30th annual report. Clin Toxicol. 2013;51(10):949–1229.

    Article  CAS  Google Scholar 

  2. Mowry JB, Spyker DA, Cantilena LR Jr, McMillan N, Ford M. 2013 annual report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 31st annual report. Clin Toxicol. 2014;52(10):1032–283.

    Article  Google Scholar 

  3. Mowry JB, Spyker DA, Brooks DE, McMillan N, Schauben JL. 2014 annual report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 32nd annual report. Clin Toxicol. 2015;53(10):962–1147.

    Article  CAS  Google Scholar 

  4. Mowry JB, Spyker DA, Brooks DE, Zimmerman A, Schauben JL. 2015 annual report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 33rd annual report. Clin Toxicol. 2016;54(10):924–1109.

    Article  CAS  Google Scholar 

  5. Gummin DD, Mowry JB, Spyker DA, Brooks DE, Fraser MO, Banner W. 2016 annual report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 34th annual report. Clin Toxicol. 2017;55(10):1072–252.

    Article  Google Scholar 

  6. Gummin DD, Mowry JB, Spyker DA, Brooks DE, Osterthaler KM, Banner W. 2017 annual report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 35th annual report. Clin Toxicol. 2018;56(12):1213–415.

    Article  Google Scholar 

  7. Wax PM, Kleinschmidt KC, Brent J, ACMT ToxIC Case Registry Investigators. The Toxicology Investigators Consortium (ToxIC) Registry. J Med Toxicol. 2011;7(4):259–65.

    Article  CAS  Google Scholar 

  8. Farrugia L, Rhyee S, Campleman SL, Judge B, Kao L, et al. The Toxicology Investigators Consortium Case Registry—the 2017 Annual Report. J Med Toxicol. 2018;14:182–211.

    Article  Google Scholar 

  9. Ruha AM, Kleinschmidt KC, Greene S, Spyres M, Brent J, et al. The epidemiology, clinical course, and management of snakebites in the North American Snakebite Registry. J Med Toxicol. 2017;13:309–20.

    Article  Google Scholar 

  10. Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap) – a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42:377–81.

    Article  Google Scholar 

  11. Morgan DL, Borys DJ, Stanford R, Kjar D, Tobleman W. Texas coral snake (Micrurus tener) bites. South Med J. 2007;100(2):152–7.

    Article  Google Scholar 

  12. Norris RL, Dart RC. Apparent coral snake envenomation in a patient without visible fang marks. Am J Emerg Med. 1989;7:402–5.

    Article  CAS  Google Scholar 

  13. Kitchens CS, Van Mierop LH. Envenomation by the eastern coral snake (Micrurus fulvius fulvius): a study of 39 victims. JAMA. 1987;258(12):1615–8.

    Article  CAS  Google Scholar 

  14. Wood A, Schauben J, Thundiyil J, Kunisaki T, Sollee D, Lewis-Younger C, et al. Review of eastern coral snake (Micrurus fulvius fulvius) exposures managed by the Florida Poison Information Center Network: 1998–2010. Clin Toxicol (Phila). 2013;51:783–8.

    Article  CAS  Google Scholar 

  15. Wyeth® Antivenin (Micrurus fulvius) (Equine Origin) North American Coral Snake Antivenin [package insert]. Accessed online Mar 25, 2020.

  16. Rappolt RT, Quinn H, Curtis L, Minton SA. Murphy JB Medical toxicologist's notebook: snakebite treatment and international antivenin index. Clin Toxicol. 1978;13:409–38.

    Article  CAS  Google Scholar 

  17. Yang DC, Dobson J, Cochran C, Dashevsky D, Arbuckle K, Benard M, et al. The bold and the beautiful: a neurotoxicity comparison of new world coral snakes in the Micruroides and Micrurus genera and relative neutralization by antivenom. Neurotox Res. 2017;32:487–95.

    Article  CAS  Google Scholar 

  18. Coral-ICP package insert. Available at http://icp.ucr.ac.cr/en/productos/coral-icp. Accessed Apr 23, 2020.

  19. Lewin M, Samuel S, Merkel J, Bickler P. Varespladib (LY315920) appears to be a potent, broad-spectrum, inhibitor of snake venom phospholipase A2 and a possible pre-referral treatment for envenomation. Toxins (Basel). 2016;8(9):248.

    Article  Google Scholar 

  20. Voss RS, Jansa SA. Snake-venom resistance as a mammalian trophic adaptation: lessons from didelphid marsupials. Biol Rev. 2012;87:822–37.

    Article  Google Scholar 

  21. Drabeck DH, Dean AM, Jansa SA. Why the honey badger don’t care: convergent evolution of venom- targeted nicotinic acetylcholine receptors in mammals that survive venomous snake bites. Toxicon. 2015;99:68–72.

    Article  CAS  Google Scholar 

  22. Massey DJ, Calvete JJ, Sánchez EE, Sanz L, Richards K, Curtis R, et al. Venom variability and envenoming severity outcomes of the Crotalus scutulatus scutulatus (Mojave rattlesnake) from southern Arizona. J Proteome. 2012;75:2576–87.

    Article  CAS  Google Scholar 

  23. Russell FE, Carlson RW, Wainschel J, Osborne AH. Snake venom poisoning in the United States experience with 550 cases. JAMA. 1975;233:341–4.

    Article  CAS  Google Scholar 

Download references

Acknowledgments

The ToxIC North American Snakebite Study Group: Kim Aldy, Peter Akpunonu, Vikhyat S. Bebarta, Gillian A. Beauchamp, Michael C. Beuhler, Mary Billington, William Boroughf, Robert D. Cannon, E. Martin Caravati, Edward Cetaruk, Alex Chen, James Chenoweth, Matthew D. Cook, Lynn Farrugia, Steven Fishburn, Erik Fisher, Jonathan B. Ford, Jakub Furmaga, Spencer Greene, Stephen Alex Harding, Benjamin Hatten, Bryan Judge, Kenneth D. Katz, William P Kerns II, Kurt Kleinschmidt, Andrew L. Koons, David B. Liss, Jennifer Lowry, Kevan Meadows, Alicia Minns, Michael Mullins, Angela PadillaJones, Tammy Phan, Lauren Porter, Ashley Carter-Powell, Sarah Shafer, Evan S. Schwarz, Meghan Spyres, Ryan M. Surmaitis, Laura Tortora, Stephanie Weiss.

The authors would like to thank Brittany Kinsey for her photograph of a Texas coral snake, Micrurus tener.

Funding

ACMT receives grant support from BTG International to support the North American Snakebite Registry. None of the authors received financial compensation for their participation in this work.

Author information

Authors and Affiliations

Authors

Consortia

Corresponding author

Correspondence to Spencer Greene.

Ethics declarations

The ToxIC Registry has approval from the Western Institutional Review Board.

Conflict of Interest

None.

Additional information

Supervising Editor: Eric J. Lavonas, MD, MS

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Greene, S., Ruha, AM., Campleman, S. et al. Epidemiology, Clinical Features, and Management of Texas Coral Snake (Micrurus tener) Envenomations Reported to the North American Snakebite Registry. J. Med. Toxicol. 17, 51–56 (2021). https://doi.org/10.1007/s13181-020-00806-3

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13181-020-00806-3

Keywords

Navigation